
    
      PROTOCOL OUTLINE: Patients receive 1 dose of von Willebrand factor concentrate. Timed blood
      studies are performed for the next 96 hours.

      Patients are followed every 2 weeks for 16 weeks, and at 24, 36, and 52 weeks.
    
  